| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |